Impaired fasting glucose as a treatment target in diabetes management

被引：0
|
作者：
Chilton R. [1 ]
Oliveros R.A. [1 ]
Zion A.S. [1 ]
Rosenberg Y. [1 ]
Selvaraj C.L. [1 ]
机构：
[1] Department of Medicine, Health Science Center, University of Texas, San Antonio, TX 78261
来源：
Current Cardiology Reports | 2009年 / 11卷 / 6期
关键词：
Fasting Plasma Glucose; Impaired Glucose Tolerance; Impaired Fasting Glucose; Hepatic Insulin Resistance; Retinal Arteriolar;
D O I：
10.1007/s11886-009-0066-0
中图分类号：
学科分类号：
摘要：
Impaired fasting glucose (IFG) contributes to microvascular and macrovascular complications and increased cardiovascular disease risk. Although type 2 diabetes is largely considered to occur as a result of IFG, understanding of physiologic and associated management targets is uniformly lacking among health care professionals. Once definitions are standardized, diagnostic criteria and screening tools may help to identify individuals at risk sooner, thereby minimizing the rapid deterioration that often results. To counter the rising pandemic of obesity and diabetes, it is important to understand the vascular risk of IFG and impaired glucose tolerance in patients at risk. © 2009 Springer Science+Business Media, LLC.
引用
收藏
页码：460 / 467
页数：7
相关论文
共 50 条
  • [41] Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
    Faerch, K.
    Borch-Johnsen, K.
    Holst, J. J.
    Vaag, A.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1714 - 1723
  • [42] Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic US Adults
    Karve, Amrita
    Hayward, Rodney A.
    [J]. DIABETES CARE, 2010, 33 (11) : 2355 - 2359
  • [43] Prediction of post challenge diabetes and impaired glucose tolerance among those without diabetes by fasting glucose
    Schmidt, MI
    Duncan, BB
    Pankow, JS
    Ballantyne, CM
    Brancati, FL
    Chambless, LE
    [J]. DIABETES, 2002, 51 : A237 - A237
  • [44] Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study
    Jonathan Golledge
    Frank Quigley
    Ramesh Velu
    Phillip J Walker
    Joseph V Moxon
    [J]. Cardiovascular Diabetology, 13
  • [45] Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study
    Golledge, Jonathan
    Quigley, Frank
    Velu, Ramesh
    Walker, Phillip J.
    Moxon, Joseph V.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [46] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
    Gerstein, H. C.
    Yusuf, S.
    Holman, R. R.
    Bosch, J.
    Anand, S.
    Avezum, A.
    Budaj, A.
    Chiasson, J.
    Conget, I.
    Dagenais, G.
    Davis, M.
    Diaz, R.
    Dinccag, N.
    Enjalbert, M.
    Escalante, A.
    Fodor, G.
    Hanefeld, M.
    Hedner, T.
    Jolly, K.
    Keltai, M.
    Laakso, M.
    Lanas, F.
    Lonn, E.
    McQueen, M.
    Mohan, V.
    Phillips, A.
    Piegas, L.
    Pirags, V.
    Probstfield, J.
    Shaw, J.
    Schmid, I.
    Teo, K.
    Zimmet, P.
    Zinman, B.
    Gerstein, H. C.
    Yusuf, S.
    Bosch, J.
    Pogue, J.
    Sheridan, P.
    Dinccag, N.
    Hanefeld, M.
    Hoogwerf, B.
    Laakso, M.
    Mohan, V.
    Shaw, J.
    Zinman, B.
    Holman, R. R.
    Diaz, R.
    Ahuad Guerrero, R.
    Albisu, J.
    [J]. LANCET, 2006, 368 (9541): : 1096 - 1105
  • [47] Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study
    R. M. van Dam
    J. M. Dekker
    G. Nijpels
    C. D. A. Stehouwer
    L. M. Bouter
    R. J. Heine
    [J]. Diabetologia, 2004, 47 : 2152 - 2159
  • [48] Is fasting plasma glucose adequate for detecting the development of diabetes in individuals with impaired glucose tolerance?
    [J]. DIABETES, 2004, 53 : A241 - A241
  • [49] Prediabetes and risk of diabetes and associated complications: impaired fasting glucose versus impaired glucose tolerance: does it matter?
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    Jayyousi, Amin
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2016, 19 (05): : 394 - 399
  • [50] High leptin levels predict development of diabetes and impaired glucose tolerance but not impaired fasting glucose in the Mauritius cohort
    Soderberg, S
    Shaw, J
    Tuomilehto, J
    Alberti, KGMM
    Zimmet, P
    [J]. DIABETES, 2002, 51 : A29 - A30
12345